REVUMENIB

UNII:	LZ0M43NNF2
Type:	INGREDIENT SUBSTANCE
Formula:	C₃₂H₄₇FN₆O₄S
Preferred Substance Name:	REVUMENIB
InChIKey:	FRVSRBKUQZKTOW-YOCNBXQISA-N
GSRS Full Record:	LZ0M43NNF2 i

2169919-21-3
2-{[4-(7-{[trans-4-(ethanesulfonamido)cyclohexyl]methyl}-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl]oxy}-N-ethyl-5-fluoro-N-(propan-2-yl)benzamide
Benzamide, N-ethyl-2-[[4-[7-[[trans-4-[(ethylsulfonyl)amino]cyclohexyl]methyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]-5-fluoro-N-(1-methylethyl)-
REVUMENIB [USAN]
Revumenib
Revumenib [MI]
Revumenib [WHO-DD]
SNDX-50613 FREE BASE
SNDX-5613 FREE BASE
SNDX50613 FREE BASE
SNDX5613 FREE BASE
revumenib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

REVUMENIB

Synonyms and Mappings

Resources